Insider Transactions in Q3 2021 at Reneo Pharmaceuticals, Inc. (RPHM)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2021
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$17,500
$7.45 P/Share
|
|
Aug 25
2021
|
Gregory J. Flesher President and CEO |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$64,000
$8.0 P/Share
|
|
Aug 25
2021
|
Vineet R. Jindal Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$35,000
$7.44 P/Share
|
|
Jul 14
2021
|
Wendy S. Johnson Chief Development Officer |
SELL
Open market or private sale
|
Direct |
111,736
-100.0%
|
$893,888
$8.5 P/Share
|
|
Jul 14
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
111,736
+5.11%
|
$893,888
$8.5 P/Share
|
|
Jul 08
2021
|
Wendy S. Johnson Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
111,736
+50.0%
|
$111,736
$1.97 P/Share
|